Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248) |
---|
07/11/2012 | CN102559599A Vero-SIAT1 cell line and application thereof |
07/11/2012 | CN102559598A Preparation and detection method for heat shock apoptosis intracranial glioma cells |
07/11/2012 | CN102558382A Method for purifying Hemophilus influenzae type b capsular polysaccharide |
07/11/2012 | CN102558355A Heterodimeric FC (fragment crystallizable) modification method based on charge network and preparation method of heterodimeric proteins |
07/11/2012 | CN102558354A Human-mouse chimeric monoclonal antibody against human platelet membrane glycoprotein Ib alpha and applications of human-mouse chimeric monoclonal antibody |
07/11/2012 | CN102558352A Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
07/11/2012 | CN102558351A Anti to human alkaline fibroblast growth factor human s c F v antibody and application thereof |
07/11/2012 | CN102558348A Single-chain antibody for resisting influenza viruses, preparation method for single-chain antibody, application of single-chain antibody |
07/11/2012 | CN102558347A Yolk antibody for treating bird flu and infectious bronchitis and preparation method thereof |
07/11/2012 | CN102558342A Pig 4-1BB receptor, gene for encoding pig 4-1BB receptor and application thereof |
07/11/2012 | CN102558341A Porcine CD28 receptor and coding gene and application thereof |
07/11/2012 | CN102558334A Peptides that selectively home to heart vasculature and related conjugates and methods |
07/11/2012 | CN102558319A Mycobacterium tuberculosis wag31 gene and application thereof |
07/11/2012 | CN102558314A HIV (human immunodeficiency virus) immunogen and preparation method thereof |
07/11/2012 | CN102558306A Antigen epitope for preventing and treating trichinosis, composition thereof and application thereof |
07/11/2012 | CN102552910A Application of extracellular matrix protein 1 and regulator thereof in preparing medicament for diagnosing or treating allergic diseases |
07/11/2012 | CN102552906A Productive technology of intravenous injection human immunoglobulin |
07/11/2012 | CN102552905A Cd40 antibody formulation and methods |
07/11/2012 | CN102552904A Recombinant molecule of human immunodeficiency virus film molecule gp120 functional domain and human TGF (Transforming Growth Factor)-beta1 |
07/11/2012 | CN102552903A Epidermal growth factor receptor (EGFR) resistance humanized monoclonal antibody preparation |
07/11/2012 | CN102552902A Preparation method of dendritic cell vaccine loaded with recombinant human gp96-Ki67 antigen peptide compound |
07/11/2012 | CN102552901A Application of fullerene derivative, as well as vaccine adjuvant and vaccine preparation thereof |
07/11/2012 | CN102552900A Artemisia pollen allergen vaccine, and preparation method and application thereof |
07/11/2012 | CN102552899A Method for preparing rabies vaccine by perfusion culture of bioreactor |
07/11/2012 | CN102552898A Purification preparation method of human rotavirus inactivated vaccines by utilizing ion exchange chromatography |
07/11/2012 | CN102552897A Prophylactic VLP (Virus-like Particle) vaccine for cervical carcinoma |
07/11/2012 | CN102552896A Preparation method of porcine reproductive and respiratory syndrome vaccines by utilizing bioreactor |
07/11/2012 | CN102552895A 疫苗组合物 Vaccine compositions |
07/11/2012 | CN102552894A Preparation method for snakehead virulent ascitesosis disease vaccine |
07/11/2012 | CN102552893A Chicken Eimeria tenella actin depolymerizing factor (ADF) recombinant bacillus calmette-guerin and preparation method thereof |
07/11/2012 | CN102552892A Mannan-modified hTRT (human Telomerase Reverse Transcriptase) gene-carrying and adeno-associated virus (AAV)-inducing targeting dendritic cell (DC) vaccine and preparation method thereof |
07/11/2012 | CN102552891A Preparation method of heat shock apoptosis glioma-loaded dendritic cell tumor vaccine |
07/11/2012 | CN102552306A Method for treating septicemia with human neutrophil peptide (HNP) blocking agents |
07/11/2012 | CN102552195A Sheet-form preparation and method for producing the same |
07/11/2012 | CN102068696B Freeze-dried powder injection with recombinant human tumor necrosis factor receptor (TNFR)-Fc fusion protein |
07/11/2012 | CN102058884B Grass carp injection vaccine synergist and preparation method thereof |
07/11/2012 | CN101905019B Porcine hemagglutinating encephalomyelitis cell culture inactivated vaccine and preparation method thereof |
07/11/2012 | CN101837122B Genetic engineering composite peptide vaccine for inhibiting tumor angiogenesis and use thereof |
07/11/2012 | CN101798348B Anti-uPAR humanized antibody and application thereof |
07/11/2012 | CN101570571B Truncated human papilloma virus 18 type L1 protein |
07/11/2012 | CN101559225B Meningococcus vaccine |
07/11/2012 | CN101559224B Poliomyelitis vaccine |
07/11/2012 | CN101525597B New hepatitis A inactivated vaccine virus strain and method for culturing same |
07/11/2012 | CN101161283B New use of CMTM1-v17 and its antagon |
07/11/2012 | CN101147803B Anti Toll-like receptor 2 antibody inhibiting tumor metastasis use |
07/11/2012 | CN101054417B Recombinant antibodies related to ganglioside and its application in diagnosing and treating tumor |
07/10/2012 | US8217159 BASB082 polynucleotides |
07/10/2012 | US8217019 AIDS virus vaccines using Sendai virus vector |
07/10/2012 | US8217016 Application of mRNA for use as a therapeutic agent for tumorous diseases |
07/10/2012 | US8216995 Relieving pain associated with muscle contractions; treating conditions such as cholinergic controlled secretions including excessive sweating, lacrimation and mucus secretions |
07/10/2012 | US8216834 Chimpanzee adenovirus vaccine carriers |
07/10/2012 | US8216805 Knobs and holes heteromeric polypeptides |
07/10/2012 | US8216792 Compositions and methods for detection and treatment of proliferative abnormalities associated with overexpression of human transketolase like-1 gene |
07/10/2012 | US8216617 Tablet comprising natural allicin and method for producing the same |
07/10/2012 | US8216595 Powerful vaccine composition comprising lipopeptide and poly I:C as an adjuvant |
07/10/2012 | US8216594 Proteins with repetitive Bacterial-Ig-like (Big) domains present in Leptospira species |
07/10/2012 | US8216593 A protozoan FusM mating protein antigen and a carrier and adjuvants; triggering a T-cell, an humoral, or a mucosal cytotoxic immune response; passively blocking the mating at the gamete in vivo; genetic engineering; antiparasiticides; antiprotozoa agents; malaria; veterinary medicine; malaria; mammals |
07/10/2012 | US8216592 Infection model for developing chemotherapeutic agents |
07/10/2012 | US8216591 With collagen and a polysaccharide such as hydroxyethyl starch as stabilizer; reduced toxicity and/or a reduced immunogenicity |
07/10/2012 | US8216590 HCV fusion polypeptides |
07/10/2012 | US8216589 HBV vaccine and a process of preparing the same |
07/10/2012 | US8216588 Lyophilized preparation comprising influenza vaccine, and method for preparation thereof |
07/10/2012 | US8216587 Method of vaccination |
07/10/2012 | US8216586 Lipases and uses thereof |
07/10/2012 | US8216585 Targeted particles and methods of using the same |
07/10/2012 | US8216584 Imaging, diagnosis and treatment of disease |
07/10/2012 | US8216583 Formulation of human antibodies for treating TNF-α associated disorders |
07/10/2012 | US8216582 Polynucleotides and polypeptide sequences involved in cancer |
07/10/2012 | US8216581 Using competitive cell surface panning to identify cells expressing preferential monoclonal antibodies; diagnosis and treatment of thrombocytopenia; thrombolytic agent |
07/10/2012 | US8216580 Sulfatases and methods of use thereof |
07/10/2012 | US8216579 Humanized FcγRIIB-specific antibodies and methods of use thereof |
07/10/2012 | US8216578 Antibodies to oncostatin M receptor |
07/10/2012 | US8216577 Anti-Aβ antibodies and their use |
07/10/2012 | US8216576 Method for inhibiting binding to B-cell receptor |
07/10/2012 | US8216574 Engineering Fc antibody regions to confer effector function |
07/10/2012 | US8216572 Antibody therapy |
07/10/2012 | US8216571 Fully human anti-VEGF antibodies and methods of using |
07/10/2012 | US8216570 TES7 and antibodies that bind thereto |
07/10/2012 | US8216569 Vascular endothelial growth factor 2 |
07/10/2012 | US8216568 Combination therapy with IgA1 proteases |
07/10/2012 | US8216564 Herpes simplex virus (HSV) derived amplicon defective viral genome carrying at least one toxic foreign gene and an HSV-derived mutant helper virus; antitumor and anticarcinogenic agents |
07/10/2012 | CA2632828C Antibodies against amyloid beta with glycosylation in the variable region |
07/10/2012 | CA2501812C Polypeptide-vaccines for broad protection against hypervirulent meningococcal lineages |
07/10/2012 | CA2485253C Lipid a and other carbohydrate ligand analogs |
07/10/2012 | CA2471838C Metal binding proteins and associated methods |
07/10/2012 | CA2462930C Remodeling and glycoconjugation of peptides |
07/10/2012 | CA2444821C Combination therapy using anti-angiogenic agents and tnfa |
07/10/2012 | CA2442053C Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters |
07/10/2012 | CA2435712C Universal carrier for targeting molecules to gb3 receptor expressing cells |
07/10/2012 | CA2429543C Method for obtaining antigenic aggregates and the use thereof in formulations |
07/10/2012 | CA2412783C Vaccine against cancerous diseases associated with the her-2/neu oncogene |
07/10/2012 | CA2402017C Compositions and methods for the early diagnosis of ovarian cancer |
07/10/2012 | CA2382336C Vaccines from infectious agents |
07/10/2012 | CA2372583C Proteins expressed by mycobacterium tuberculosis and not by bcg and their use as diagnostic reagents and vaccines |
07/10/2012 | CA2326499C Methods of selecting internalizing antibodies |
07/10/2012 | CA2305816C Peptides capable of inhibiting the interaction between presenilins and the .beta.-amyloid peptide or its precursor |
07/05/2012 | WO2012092569A2 Compositions comprising immunostimulatory nucleic acids and related methods |
07/05/2012 | WO2012092552A1 Synthetic nanocarriers with reactive groups that release biologically active agents |
07/05/2012 | WO2012092469A2 Clostridium difficile antigens |
07/05/2012 | WO2012092226A1 Veterinary vaccine composition against infections caused by salmonella |